Forte BioSciences Inc(FBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FBRX Forte BioSciences Inc

盘前交易 08-14 04:00:53 EDT

76.86

+0.08

+0.10%

最高76.88	最低76.78	成交量115.06万
今开76.82	昨收76.78	日振幅0.12%
总市值16.32亿	流通市值15.06亿	总股本2,123万
成交额8,840万	换手率5.87%	流通股本1,959万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FBRX","market":"US","secType":"STK","nameCN":"Forte BioSciences Inc","latestPrice":76.86,"timestamp":1786651200000,"preClose":76.78,"halted":0,"volume":1150594,"delay":0,"changeRate":0.0010419380046886987,"floatShares":19594427,"shares":21229100,"eps":-4.645887,"marketStatus":"盘前交易","change":0.08,"latestTime":"08-14 04:00:53 EDT","open":76.82,"high":76.875,"low":76.78,"amount":88400654.7873,"amplitude":0.001237,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.645887,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786714200000},"marketStatusCode":1,"adr":0,"listingDate":1492056000000,"exchange":"NASDAQ","adjPreClose":76.86,"postHourTrading":{"tag":"盘后","latestPrice":76.86,"preClose":76.86,"latestTime":"19:52 EDT","volume":593,"amount":45577.8435,"timestamp":1786665122247,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8676047543670695,"impliedVol":0.0297,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/FBRX","defaultTab":"news","newsList":[{"id":"2657314546","title":"Argenx SE（ARGX）正式发起要约收购 拟全现金吞并Forte（FBRX）","url":"https://stock-news.laohu8.com/highlight/detail?id=2657314546","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657314546?lang=zh_cn&edition=full","pubTime":"2026-08-06 20:37","pubTimestamp":1786019826,"startTime":"0","endTime":"0","summary":"Argenx拟以每股77.00美元的现金价格收购Forte所有已发行及流通在外的普通股，要约收购自2026年8月6日正式开启，将于美东时间2026年8月26日到期。不过，该交易还需要获得代表Forte已发行股份超50%的有效预先要约与接纳，也须符合美国HSR法案的等待期届满或提前终止。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303516","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","FMED","LU0320765992.SGD","IE00B4R5TH58.HKD","ARGX","BK4505","IE0034235188.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2324357040.USD","BK4588","IBB","LU0823416689.USD","FBRX","BK4585","TBXU","BK4139","EVNT","IE00B2B36J28.USD","LU1983260115.SGD","LU0109394709.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167573014","title":"Forte BioSciences盘前爆升39%，Argenx将以每股77美元现金收购Forte Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=1167573014","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167573014?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:34","pubTimestamp":1785144847,"startTime":"0","endTime":"0","summary":"$Forte BioSciences Inc$ 盘前爆升 39%，消息面上，Argenx将以每股77美元现金收购Forte Biosciences。免疫学公司argenx周一表示，公司将收购美国生物制药公司Forte Biosciences，以将其实验性自身免疫药物FB102纳入自身产品组合。根据交易条款，argenx将以每股77美元现金收购Forte Biosciences，对这家美国药物开发公司的估值约为22亿美元。此次交易将使argenx获得一种同类首创的抗CD122抗体药物。该药物在治疗**白癜风和乳糜泻**方面已显示出早期潜力。","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654701617","title":"Forte Biosciences美股盘前大涨近39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654701617","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654701617?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:27","pubTimestamp":1785144463,"startTime":"0","endTime":"0","summary":"ForteBiosciences美股盘前大涨近39%，公司获荷兰生物科技企业ArgenxSE豪掷22亿美元溢价收购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607273822201614.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607273822201614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654097843","title":"Argenx(ARGX.US)豪掷22亿美元、溢价40%收购Forte Biosciences(FBRX.US) 加码布局免疫学药物组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2654097843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654097843?lang=zh_cn&edition=full","pubTime":"2026-07-27 14:52","pubTimestamp":1785135121,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ARGX","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4588","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","IBB","LU2324357040.USD","LU1983260115.SGD","IE0002141913.USD","IE0034235188.USD","FBRX","BK4139","IE0009355771.USD","LU0889565916.HKD","LU0320765992.SGD","BK4505","IE00B2B36J28.USD","TBXU","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145887507","title":"Argenx豪掷22亿美元、溢价40%收购Forte Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=1145887507","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145887507?lang=zh_cn&edition=full","pubTime":"2026-07-27 13:08","pubTimestamp":1785128915,"startTime":"0","endTime":"0","summary":"7月27日，ForteBiosciences美股夜盘飙升逾22%，Argenx将以每股77美元的价格对其进行现金收购。全球免疫学创新公司 argenx和Forte Biosciences, Inc.今天宣布，两家公司已达成最终协议，根据该协议，argenx 将以每股 77 美元的现金收购 Forte Biosciences，总股权价值约为 22 亿美元。Forte Biosciences 的主导项目 FB102 的加入，进一步拓展了 argenx 的差异化免疫学药物产品组合。此次收购体现了 argenx 严谨的研发策略，致力于为患者发现并推进突破性科学，以期重新定义数十年来缺乏实质性创新疗法的疾病的治疗标准。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Argenx豪掷22亿美元、溢价40%收购Forte Biosciences","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX","FBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107526184","title":"FB102展现强劲安全性，不良反应仅轻至中度","url":"https://stock-news.laohu8.com/highlight/detail?id=1107526184","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107526184?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:05","pubTimestamp":1783598725,"startTime":"0","endTime":"0","summary":"Forte BioSciences Inc 的候选药物FB102在临床试验中表现出良好的安全性，所报告的不良反应事件均为轻至中度级别。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616556674","title":"Forte Biosciences, Inc.盘中异动 股价大涨7.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616556674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2616556674?lang=zh_cn&edition=full","pubTime":"2026-03-03 23:42","pubTimestamp":1772552539,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日23时42分，Forte Biosciences, Inc.股票出现异动，股价急速拉升7.18%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.62%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃和1型糖尿病等适应症方面具有广泛的自身免疫应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603032342199542d705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603032342199542d705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518820836","title":"Forte Biosciences, Inc.盘中异动 股价大跌8.92%报5.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518820836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518820836?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:47","pubTimestamp":1741621667,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时47分，Forte Biosciences, Inc.股票出现异动，股价大幅跳水8.92%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310234748abf32ded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310234748abf32ded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","BK4139","BK4588","BK4153","FBRX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517986493","title":"Forte Biosciences, Inc.盘中异动 临近收盘快速下跌5.60%报7.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517986493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517986493?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:59","pubTimestamp":1741121997,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时59分，Forte Biosciences, Inc.股票出现波动，股价快速下跌5.60%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030504595796399e7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030504595796399e7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","BK4153","FBRX","AA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516965148","title":"Forte Biosciences, Inc.盘中异动 大幅下挫5.49%报8.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516965148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516965148?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:32","pubTimestamp":1741023154,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时32分，Forte Biosciences, Inc.股票出现异动，股价快速跳水5.49%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304013234a25d761e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304013234a25d761e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","BK4139","BK4588","BK4585","FBRX","BK4153"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516376084","title":"Forte Biosciences, Inc.盘中异动 快速上涨5.27%报9.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516376084?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:59","pubTimestamp":1740758382,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时59分，Forte Biosciences, Inc.股票出现异动，股价急速上涨5.27%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228235942a25817d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228235942a25817d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBRX","BK4588","BK4585","AA","BK4153","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514012863","title":"Forte Biosciences, Inc.盘中异动 快速拉升9.10%报10.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514012863?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:20","pubTimestamp":1740590437,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时20分，Forte Biosciences, Inc.股票出现波动，股价急速上涨9.10%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022701203796316ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022701203796316ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4153","BK4588","BK4139","FBRX","AA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514190580","title":"Forte Biosciences, Inc.盘中异动 早盘急速下挫5.08%报9.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514190580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514190580?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:22","pubTimestamp":1740500543,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时22分，Forte Biosciences, Inc.股票出现异动，股价大幅跳水5.08%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002223abdc98a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002223abdc98a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","FBRX","BK4153","AA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514703473","title":"Forte Biosciences, Inc.盘中异动 临近收盘大幅跳水5.69%报10.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514703473?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:36","pubTimestamp":1740429414,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时36分，Forte Biosciences, Inc.股票出现异动，股价快速下挫5.69%。截至发稿，该股报10.36美元/股，成交量4.2914万股，换手率0.67%，振幅8.01%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043654abdb5a8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225043654abdb5a8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","FBRX","AA","BK4153","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512162079","title":"Forte Biosciences, Inc.盘中异动 快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512162079?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:39","pubTimestamp":1739896747,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时39分，Forte Biosciences, Inc.股票出现波动，股价快速拉升5.00%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190039079627ad10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190039079627ad10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBRX","BK4588","BK4585","AA","BK4153","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511457107","title":"Forte Biosciences, Inc.盘中异动 股价大涨6.36%报11.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511457107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511457107?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:53","pubTimestamp":1739476424,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时53分，Forte Biosciences, Inc.股票出现异动，股价急速拉升6.36%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021403534598846a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021403534598846a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","FBRX","BK4585","BK4139","BK4588","BK4153"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510354514","title":"Forte Biosciences, Inc.盘中异动 临近收盘股价大涨8.12%报11.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510354514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510354514?lang=zh_cn&edition=full","pubTime":"2025-02-12 04:30","pubTimestamp":1739305817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日04时30分，Forte Biosciences, Inc.股票出现异动，股价快速上涨8.12%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.92%。其相关个股中，Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3221.48%、1525.42%、515.46%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、72.23%、64.94%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212043017a242461b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212043017a242461b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","OMGA","BK4539","BK4153","BK4588","FBRX","OCEA","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510605728","title":"Forte Biosciences, Inc.盘中异动 股价大跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510605728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510605728?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:51","pubTimestamp":1739206274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时51分，Forte Biosciences, Inc.股票出现异动，股价快速跳水6.38%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211005115abc9c30d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211005115abc9c30d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4153","FBRX","AA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744178","title":"Forte Biosciences, Inc.盘中异动 大幅上涨5.77%报13.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509744178?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:32","pubTimestamp":1738938730,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时32分，Forte Biosciences, Inc.股票出现波动，股价大幅上涨5.77%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223210a23d2371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223210a23d2371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBRX","AA","BK4139","BK4585","BK4588","BK4153"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509270246","title":"Forte Biosciences, Inc.盘中异动 股价大涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509270246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509270246?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:17","pubTimestamp":1738855021,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时17分，Forte Biosciences, Inc.股票出现波动，股价急速拉升5.80%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206231701a23bd960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206231701a23bd960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4153","FBRX","BK4139","AA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortebiorx.com","stockEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.7792},{"period":"3month","weight":2.3258},{"period":"6month","weight":1.3936},{"period":"1year","weight":6.2715},{"period":"ytd","weight":1.8185}],"compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.141},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.1407}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Forte Biosciences, Inc.是一家临床阶段的皮肤病学公司，致力于开发用于治疗炎症性皮肤病的活体生物疗法FB-401。 FB-401已完成对成人和儿童（3岁及以上）特应性皮炎患者的1/2a期测试。 对于安全和有效的疗法，特别是对于小儿特应性皮炎患者，存在大量的需求。Forte计划在2020年代中期将FB-401推进到2期临床试验中。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.020804},{"month":2,"riseRate":0.444444,"avgChangeRate":0.109082},{"month":3,"riseRate":0.444444,"avgChangeRate":0.002551},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.045955},{"month":5,"riseRate":0.5,"avgChangeRate":-0.052889},{"month":6,"riseRate":0.4,"avgChangeRate":0.035403},{"month":7,"riseRate":0.3,"avgChangeRate":0.219651},{"month":8,"riseRate":0.6,"avgChangeRate":0.014044},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.106302},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.15298},{"month":11,"riseRate":0.555556,"avgChangeRate":0.494702},{"month":12,"riseRate":0.555556,"avgChangeRate":0.04489}],"exchange":"NASDAQ","name":"Forte BioSciences Inc","nameEN":"Forte BioSciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Forte BioSciences Inc(FBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Forte BioSciences Inc(FBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Forte BioSciences Inc,FBRX,Forte BioSciences Inc股票,Forte BioSciences Inc股票老虎,Forte BioSciences Inc股票老虎国际,Forte BioSciences Inc行情,Forte BioSciences Inc股票行情,Forte BioSciences Inc股价,Forte BioSciences Inc股市,Forte BioSciences Inc股票价格,Forte BioSciences Inc股票交易,Forte BioSciences Inc股票购买,Forte BioSciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Forte BioSciences Inc(FBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Forte BioSciences Inc(FBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}